Amanote Research
Register
Sign In
Advanced Glycation Endproducts in Multiple Sclerosis
doi 10.26481/dis.20190221sw
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
University of Maastricht
Related search
Receptor for Advanced Glycation Endproducts (RAGE)
Science-Business eXchange
Receptor for Advanced Glycation Endproducts Mediates Pro-Atherogenic Responses to Periodontal Infection in Vascular Endothelial Cells
Atherosclerosis
Cardiovascular Medicine
Cardiology
Receptor for Advanced Glycation Endproducts Controls Deleterious Lung Inflammation in Severe Pseudomonas Aeruginosa Pneumonia in Immunosuppressed Mice
Critical Care
Critical Care
Intensive Care Medicine
Morphological Changes Induced by Advanced Glycation Endproducts in Osteoblastic Cells: Effects of Co-Incubation With Alendronate
Acta Histochemica
Medicine
Histology
Cell Biology
Advanced Glycation Endproducts Inhibit Prostacyclin Production and Induce Plasminogen Activator Inhibitor-1 in Human Microvascular Endothelial Cells
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Imaging the Effect of Receptor for Advanced Glycation Endproducts on Angiogenic Response to Hindlimb Ischemia in Diabetes
EJNMMI Research
Nuclear Medicine
Radiology
Imaging
The Expression of the Receptor for Advanced Glycation Endproducts (RAGE) Is Permissive for Early Pancreatic Neoplasia
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Age-Dependent Accumulation of Advanced Glycation Endproducts Is Accelerated in Combined Hyperlipidemia and Hyperglycemia, a Process Attenuated by L-Arginine
AGE
Soluble Levels of Receptor for Advanced Glycation Endproducts (sRAGE) and Coronary Artery Disease: The Next C-Reactive Protein?
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
